Skip to content

Effect of different red blood cells transfusion strategies on the outcome of neurocritical patients: a randomized controlled study

Effect of different red blood cells transfusion strategies on the outcome of neurocritical patients: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083713
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subarachnoid hemorrhage, traumatic brain injury, cerebral hemorrhage

Interventions

liberal transfusion strategy group:Patients in the liberal transfusion strategy group will not receive an allogeneic RBC transfusion when hemoglobin is over 90 g/L after IAT. Patients will receive an
restrictive transfusion strategy group:Patients in the restrictive transfusion strategy group will not receive an allogeneic RBC transfusion when hemoglobin is over 70 g/L after IAT. Patients will rec

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) 18 years=age=65 years (2) proposed craniotomy hematoma removal for acute brain injury (traumatic brain injury/subarachnoid hemorrhage/cerebral hemorrhage) (3) hemoglobin concentrations below 90 g/L (4) signed informed consent

Exclusion criteria

Exclusion criteria: (1) life-threatening patients in need of emergency treatment (2) patients with severe heart disease (3) pregnant or lactating women (4) patients who have already received a red blood cell infusion before surgery (5) patients who refuse transfusion (6) patients with Glasgow outcome scale=3, patients with dilated and fixed pupils (7) patients with clinically diagnosed brain death

Design outcomes

Primary

MeasureTime frame
GOSe score at discharge;

Secondary

MeasureTime frame
GOS-E score at 6 months postoperatively;Mortality in hospitals;Transfusion-related adverse reactions;Systemic complications;Length of stay in ICU;

Countries

China

Contacts

Public ContactYu Yun

Beijing Tiantan Hospital Affiliated to Capital Medical University

yy_waitou@163.com+86 138 1148 9180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026